Ipca Laboratories Limited is hosting a walk-in interview for fresh graduates on November 1, 2026, aimed at recruiting for its Production API training program within the Center of Excellence (CoE). This opportunity is open to candidates who graduated between 2023 and 2026 with qualifications such as a B.Sc. in Chemistry, a Diploma in Chemical Engineering, or a B.Tech in Chemical Engineering. Those selected will receive a monthly stipend of ₹12,300 throughout the three-month training period, along with complimentary canteen and transportation services. Upon successful completion of the training, candidates may be offered positions at Ipca Laboratories with a compensation package ranging from ₹2.67 LPA to ₹3.67 LPA, contingent upon their skills and compatibility. The walk-in interview will take place on November 1, 2026, from 10:00 AM to 4:00 PM at the Ipca Laboratories Limited facility located at Plot No. 16–22, Industrial Area No. 1, AB Road, Dewas, Madhya Pradesh.
Vacancy details
Department: Production API
Role: Trainee
Experience: Freshers
Qualification: B.Sc. Chemistry / Diploma & B.Tech in Chemical Engineering Chemical Engineering
Year of pass: 2023, 2024, 2025, 2026
Training Details
Name of Programme: Center of Excellence
Training Duration: 3 Months
Monthly Stipend: ₹12,300
Post-Training CTC: ₹2.67 LPA to ₹3.67 LPA
Training Location: Center of Excellence, Dewas (API)
Walk-in interview details
Date of interview: 1 November 2026 (Saturday)
Interview Time: 10:00 AM – 4:00 PM
Interview Venue: Ipca Laboratories Limited, Plot No. 16–22, Industrial Area No. 1, AB Road, Dewas, Madhya Pradesh.
Contact Information
For recruitment-related concerns, the poster provides the following email addresses:
ipca@ipca.com
corporate.communication@ipca.com

About Ipca Laboratories Limited
Ipca Laboratories is a leading pharmaceutical company known for its commitment to quality, safety, integrity, and dignity. It operates across various continents and has recently reported better-than-expected performance in its financial results for the third quarter of FY25.
